中国药业2025，Vol.34Issue(16)：35-39,5.DOI:10.3969/j.issn.1006-4931.2025.16.006
DRG支付模式下胆囊结石并急性胆囊炎临床路径用药优化与经济性评价
Optimization of Medication Use and Economic Evaluation of Clinical Pathway for Gallstones Combined with Acute Cholecystitis Under DRG Payment Mode
摘要
Abstract
Objective To investigate the rationality and economic evaluation of inpatients with gallstones combined with acute cholecystitis before and after the optimization of clinical pathway under disease diagnosis related group(DRG)payment mode.Methods Patients with gallstones combined with acute cholecystitis who underwent laparoscopic cholecystectomy in the Department of Hepatobiliary and Pancreatic Surgery of the hospital from October to December 2020(before the optimization of clinical pathway,38 cases)and from October to December 2021(after the optimization of clinical pathway,42 cases)were selected and divided into the observation group and the control group according to the DRG grouping principle.Based on the medication information of patients in the control group,the medication rationality suggestions were put forward to form the clinical pathway,and then the patients with the same pathway were extracted for medication analysis,the rationality and economy of medication in the two groups were compared.Results In terms of rationality,the usage rates of proton pump inhibitors and hemostatic drugs in the observation group were significantly lower than those in the control group(P<0.05).In terms of economy,the average cost percase of antibiotics,analgesics,and hepatoprotective drugs,the average drug cost,total cost and the drug expenditure ratio in the observation group were significantly lower than those in the control group,and the length of hospital stay in the observation group was significantly shorter than that in the control group(P<0.05).Conclusion Based on the DRG payment mode,optimizing the clinical pathway can further standardize the rationality of medication for patients with gallstone combined with acute cholecystitis,and improve the economy of medication.关键词
疾病诊断相关分组/临床路径/合理用药/胆囊结石/急性胆囊炎Key words
clinical pathway/disease diagnosis related grouping/rational drug use/gallstone/acute cholecystitis分类
医药卫生引用本文复制引用
徐超然,杨玉洁,崔芬芳,徐敏..DRG支付模式下胆囊结石并急性胆囊炎临床路径用药优化与经济性评价[J].中国药业,2025,34(16):35-39,5.基金项目
四川省成都市医学科研课题项目[2023210]. （）
